文献速递消化道肿瘤与早癌消化内镜

胃黏膜肠上皮化生患者5年随访期间的胃癌风险

The risk of gastric cancer in patients with gastric intestinal metaplasia in 5-year follow-up.
PubMed 文献 · Aliment Pharmacol Ther · 2017-04-27

这项回顾性队列研究纳入2004至2014年诊断的91例胃黏膜肠上皮化生(GIM)患者,每6至12个月行食管胃十二指肠镜监测,随访至诊断胃癌或完成5年随访。完全型GIM患者未发生癌变,而不完全型GIM患者中5/10(50%)进展为高级别异型增生(2例)或癌(3例)。男性(P=.027)和不完全型GIM(P=.001)与随访结束时的高风险组织学(异型增生或癌)相关,吸烟呈现可能关联的趋势(P=.08)。

要点

  • 完全型GIM患者随访期间未发生癌变。
  • 不完全型GIM患者中50%(5/10)进展为高级别异型增生或癌。
  • 男性(P=.027)和不完全型GIM(P=.001)与高风险组织学相关。

核心结论

  • 男性和不完全型GIM患者发生异型增生或早期胃癌的风险最高。
  • 仍需进一步研究以确定最佳监测间隔及其对癌症发病率和死亡率的影响。

研究设计与样本

  • 回顾性队列研究,纳入2004至2014年诊断的91例GIM患者,行监测性食管胃十二指肠镜(EGD)每6至12个月一次,直至诊断胃癌或完成计划的5年随访。
  • 评估胃癌的可能危险因素。

主要发现

  • 初诊时91例患者中81例(89%)为完全型GIM,其余11%为研究入组时诊断的不完全型GIM。
  • 完全型GIM患者中未发生癌症;而不完全型GIM的10例患者中有5例(50%)进展为高级别异型增生(n=2)或癌(n=3)。
  • 随访结束时,男性(P=.027)和不完全型GIM(P=.001)与高风险组织学(异型增生或癌)相关。
  • 吸烟呈现可能关联的趋势(P=.08)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastric intestinal metaplasia (GIM) is the premalignant stage of gastric cancer; however, consensus on its management has not been established. AIM: To determine the risk factors for gastric cancer in a population of patients with GIM to guide the appropriate clinical recommendations in a low prevalence area for gastric cancer. METHODS: This was a retrospective cohort study. Ninety-one patients with GIM diagnosed between 2004 and 2014 were recruited for surveillance EGD every 6-12 months until a diagnosis of gastric cancer or completion of the planned 5-year follow-up duration. Possible risk factors for gastric cancer were assessed. RESULTS: At initial presentation, 81 of the 91 patients (89%) had complete GIM, whereas the remaining 11% had a study entry diagnosis of incomplete GIM. No cancer developed amongst patients with complete GIM. In contrast, five of the 10 patients exhibiting incomplete GIM (50%) progressed to high-grade dysplasia (n=2) or cancer (n=3). Male gender (P=.027), and incomplete GIM (P=.001) were associated with high-risk histology (dysplasia or cancer) by study end. A trend suggested a possible association with smoking (P=.08). CONCLUSION: Male patients and those with incomplete GIM are at greatest risk of developing dysplasia or early gastric cancer. Further studies in determining optimal surveillance intervals and impact on cancer incidence and mortality are still required.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Pittayanon R, Rerknimitr R, Klaikaew N, et al. The risk of gastric cancer in patients with gastric intestinal metaplasia in 5-year follow-up. Aliment Pharmacol Ther. 2017. PMID: 28449219. doi:10.1111/apt.14082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。